Pharmaceutical Caps & Closures Market Aims for a Projected Reach of US$ 4,469.4 Million with a 5.8% CAGR by 2033-FMI Study

The pharmaceutical caps and closures market is anticipated to expand at a 5.8% CAGR over the forecast period, based on FMI’s analysis. It is anticipated that the industry would reach a market size of US$ 2,541.5 million by 2023.

In the pharmaceutical industry, closures that constitute the container-closure system, are considered important in the packaging of sterile products. Pharmaceutical closures, variously called bungs or stoppers, are an important element of the final packaging of pharmaceutical preparations.

The use of pharmaceutical caps and closures ensures parenteral pharmaceuticals’ sterility. These also avert the entrance of contamination upon the insertion of a needle into a vial. Packaging solutions safeguard the drug from physical damage and even from biological degradation.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13237

Drugs sensitive to water, light, and sometimes proximity to another sensitive substance, require effective caps and closures solutions. Increasing cases of chronic disorders and increasing administration of drugs are fueling the demand for caps and closures in pharmaceuticals. Moreover, favorable government policies and accelerating healthcare infrastructure are also fueling the market growth.

Growing demand for packaging in the pharmaceutical industry to protect the drugs from any external influences is projected to spur market growth. Companies active in the industry are offering an array of packaging solutions that cater to the needs of the pharmaceutical and healthcare industry while complying with strict industry standards.

Top Highlights from the FMI’s Analysis:

• North America’s pharmaceutical caps and closures industry gained a 29.6% market share in 2022.
• The United States pharmaceutical caps and closures industry is expected to acquire more than 26.5% in 2023.
• Europe region procured a 27.8% market share in 2022. Germany’s pharmaceutical caps and closures industry obtained a 4.8% market share in the same year.
• The United Kingdom market is projected to expand at a CAGR of 7.3% in the coming decade.
• In Asia Pacific, China, and India are projected to expand at a CAGR of 8.3% and 6.8%, respectively, in the forecast period.
• Australia’s pharmaceutical caps and closures industry is anticipated to expand at a CAGR of 4.5% from 2023 to 2033.
• Japan’s pharmaceutical caps and closures industry acquired a 6.4% market share, globally.
• Based on product, screw caps, and closures are projected to constitute 46.96% of the global market.
• Based on functionality, tamper evident segment is predicted to form more than 64.06% of the global market.
• Under the material category, the plastics segment is anticipated to contribute 60% to the global market.
• Based on drug modality, small molecules (synthetic drugs) secured 59.4% of the global market in 2022.
• Based on therapeutic class, anticancer drugs acquired a share of 20.5% in 2022.
• Based on end users, the pharmaceutical & biotechnology companies segment gained 52.8% of the entire market in 2022.

Market Update: Key Innovations Taking Place in this Market:

• Silgan Holdings acquired the dispensing business of Albea, which is a packaging firm, in June 2020. The dispensing business distributes sprayers, pumps, and foam dispensing solutions to large consumer goods firms. The business is operational in Europe, Asia, North America, and South America.
• Berry Global Group obtained RPC Group in July 2020. This acquisition helped in the positioning of the company as the global leader in value-added protective solutions and a significant plastic packaging company. Furthermore, the company has widened its global footprint spanning 290 locations the world over.

Key Players:

• Berry Global Inc.
• Amcor Plc
• Aptar, Inc.
• Closure Systems International, Inc.
• O.Berk Company, LLC
• Bericap GmbH and Co KG
• UNITED CAPS
• CL Smith Company
• Georg MENSHEN GmbH & Co. KG
• WestRock Company
• West Pharmaceutical Services, Inc

Market by Categorization:

By Product Type:

• Screw Caps & Closure
• Snap Caps & Closure
• Push-Pull Caps & Closure
• Stopper & Seals
• Others

By Functionality:

• Child Resistant
• Tamper-evident

By Material type:

• Plastic
• Elastomer
• Metal

By availability:

• Prescription (Rx) Pharmaceuticals
• Over-the-Counter (OTC) Pharmaceuticals

By Drug Modality:

• Small Molecule (Synthetic Drugs)
• Biopharmaceuticals

By Therapeutic class:

• Anticancer Drugs
• Anti-infective Drugs
• Anti-viral Drugs
• Anti-bacterial Drugs
• Anti-fungal Drugs
• Others
• Cardiovascular Drugs
• Anti-inflammatory Drugs
• Analgesics Drugs
• Anti-diabetics
• Ophthalmic Drugs
• Neurological Drugs
• Others

Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-13237

By End Users:

• Pharmaceutical & Biotechnology Companies
• Contract Manufacturing Organizations (CMO)
• Contract Research Organizations (CROs)
• Academic & Research Institutes

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube